
|Articles|January 15, 2004
Prostaglandin analogs help patients stick with regimen
Author(s)Cheryl Guttman
Baltimore-Patients prescribed latanoprost (Xalatan, Pfizer Ophthalmics) continue therapy significantly longer than their counterparts using other prostaglandin-type drugs, according to the results of a population-based, retrospective cohort study.
Advertisement
Newsletter
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
Ocular Therapeutix reaches target enrollment of 555 patients in SOL-R trial
2
Nanoscope Therapeutics releases positive long-term safety results from EXTEND study
3
4DMT and Otsuka Pharmaceutical partner on 4D-150 in the greater Asia-Pacific region
4
Sydnexis reports positive phase 3 results for SYD-101 in pediatric myopia
5


















































.png)


